Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation

VIVUS INC (VVUS) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/08/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
01/05/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
12/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/29/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/29/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/29/2020 RW Form RW - Registration Withdrawal Request:
12/29/2020 RW Form RW - Registration Withdrawal Request:
11/16/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date"
11/13/2020 GN VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date
08/17/2020 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/11/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/03/2020 CT ORDER Form CT ORDER - Confidential treatment order:
07/23/2020 CT ORDER Form CT ORDER - Confidential treatment order:
07/13/2020 8-K Quarterly results
07/07/2020 8-K Quarterly results
07/07/2020 GN VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC
06/19/2020 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
06/19/2020 8-K Quarterly results
06/19/2020 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/08/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/02/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P. CAMPBELL, CA., June 2, 2020 — VIVUS, Inc. , a biopharmaceutical company, today announced that it has updated its agreement regarding its corporate debt with Icahn Enterprises Holdings L.P. , which holds a principal amount of approximately $170.2 million of the Company's Convertible Senior Notes."
06/02/2020 GN VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.
05/08/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy